Yanli Cheng Selected Research

Triglycerides (Triacylglycerol)

1/2019

Scutellarin Exerts Hypoglycemic and Renal Protective Effects in db/db Mice via the Nrf2/HO-1 Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanli Cheng Research Topics

Disease

7	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 12/2015
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 12/2015
3	Type 2 Diabetes Mellitus (MODY) 07/2020 - 12/2015
3	Inflammation (Inflammations) 01/2019 - 04/2016
2	Hypoxia (Hypoxemia) 01/2022 - 01/2019
2	Glioma (Gliomas) 01/2022 - 12/2018
2	Fibrosis (Cirrhosis) 01/2019 - 04/2016
1	Hemophilia A (Haemophilia) 11/2022
1	Hemorrhage 11/2022
1	Synovial Sarcoma (Synovioma) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Obesity 01/2021
1	Insulin Resistance 07/2020
1	Weight Gain 05/2020
1	Atherosclerosis 05/2020
1	Membranous Glomerulonephritis (Membranous Nephropathy) 11/2019
1	Body Weight (Weight, Body) 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Neoplasms (Cancer) 12/2018
1	Neoplasm Metastasis (Metastasis) 12/2018
1	Diabetic Cardiomyopathies 01/2017
1	Lung Neoplasms (Lung Cancer) 06/2016
1	Ulcer 02/2015

Drug/Important Bio-Agent (IBA)

3	AntioxidantsIBA 07/2020 - 12/2015
3	Fenofibrate (CiL)FDA LinkGeneric 01/2020 - 04/2016
3	CollagenIBA 01/2019 - 04/2016
3	sulforaphaneIBA 01/2017 - 12/2015
3	MetallothioneinIBA 01/2017 - 12/2015
2	LipidsIBA 01/2021 - 04/2016
2	fibroblast growth factor 21IBA 01/2020 - 04/2016
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2017
1	Factor VIII (Coagulation Factor VIII)IBA 11/2022
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 11/2022
1	Receptor for Advanced Glycation End ProductsIBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	NestinIBA 01/2022
1	ChromatinIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	PalmitatesIBA 01/2021
1	Glucose Transporter Type 4IBA 07/2020
1	MagnesiumIBA 07/2020
1	Interleukin-6 (Interleukin 6)IBA 05/2020
1	Apolipoproteins E (ApoE)IBA 05/2020
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2020
1	Immunoglobulin G (IgG)IBA 11/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Clopidogrel (Plavix)FDA Link 01/2019
1	Histones (Histone)IBA 01/2019
1	HDL CholesterolIBA 01/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Fibronectins (Fibronectin)IBA 01/2019
1	Pyruvate KinaseIBA 01/2019
1	CholesterolIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	VimentinIBA 12/2018
1	Messenger RNA (mRNA)IBA 12/2018
1	CateninsIBA 12/2018
1	Cadherins (E-Cadherin)IBA 12/2018
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 12/2018
1	Tissue Inhibitor of MetalloproteinasesIBA 12/2018
1	Cyclin D1IBA 12/2018
1	Matrix Metalloproteinases (MMPs)IBA 12/2018
1	Myosin Type IIIBA 12/2018
1	ZincIBA 03/2018
1	9-deaza-9-(3-thienylmethyl)guanineIBA 06/2016
1	PPAR alphaIBA 04/2016
1	Sirtuin 1IBA 04/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2015

Therapy/Procedure

1	Injections 11/2022
1	Oral Administration 01/2019